1 Min Read
Dec 6 (Reuters) - Azurrx Biopharma Inc:
* Azurrx Biopharma announces agreement in principle with transchem for MTAN inhibition technology Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.